Literature DB >> 15950133

Dyspnea and leg effort during exercise.

Loredana Stendardi1, Michela Grazzini, Francesco Gigliotti, Pamela Lotti, Giorgio Scano.   

Abstract

Dyspnea and leg effort are the major symptoms limiting exercise in healthy subjects and in patients with a variety of respiratory disorders. Quantitative measurement of both symptoms may be obtained by category scales such as VAS and Borg, with the latter being widely used. Furthermore, descriptor clusters of dyspnea help to assess some of the reasons for stopping exercise. The intensity of dyspnea and leg effort are similar in different disease states; this symmetry suggests that the limiting discomfort is a function of the intensity of increased motor drive to peripheral and respiratory muscles. An alternative explanation for the factors which limit exercise is that the subjects stop exercise volitionally when the discomfort associated with continuing exercise exceeds that which they are willing to tolerate. Muscle strength contributes to the intensity of dyspnea and leg effort at a given power output: the greater the muscle force, the lower the symptom. Symptoms also correlate with intensity and duration of a task by a power function in such a way that when minimizing the intensity of a given muscular task by prolonging the duration of activity, the symptom is drastically reduced. Skeletal muscle fatigue may be a factor limiting exercise tolerance both in healthy subjects and in patients with cardiorespiratory disorders. In conclusion, symptom measurement complements physiological measurements, both being essential to a comprehensive understanding of exercise tolerance.

Entities:  

Mesh:

Year:  2005        PMID: 15950133     DOI: 10.1016/j.rmed.2005.02.005

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  8 in total

1.  MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study.

Authors:  Effrosyni D Manali; Panagiotis Lyberopoulos; Christina Triantafillidou; Likourgos F Kolilekas; Christina Sotiropoulou; Joseph Milic-Emili; Charis Roussos; Spyros A Papiris
Journal:  BMC Pulm Med       Date:  2010-05-28       Impact factor: 3.317

2.  Local Pain Dynamics during Constant Exhaustive Exercise.

Authors:  Agne Slapsinskaite; Selen Razon; Natàlia Balagué Serre; Robert Hristovski; Gershon Tenenbaum
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

3.  Clinical and symptomatological reflections: the fascial system.

Authors:  Bruno Bordoni; Emiliano Zanier
Journal:  J Multidiscip Healthc       Date:  2014-09-18

4.  Respiratory muscle endurance is limited by lower ventilatory efficiency in post-myocardial infarction patients.

Authors:  Laura M T Neves; Marlus Karsten; Victor R Neves; Thomas Beltrame; Audrey Borghi-Silva; Aparecida M Catai
Journal:  Braz J Phys Ther       Date:  2014-02-01       Impact factor: 3.377

5.  Older phase 2 cardiac rehabilitation patients engaged in gardening maintained physical function during the COVID-19 pandemic.

Authors:  Asami Ogura; Kazuhiro P Izawa; Hideto Tawa; Fumie Kureha; Masaaki Wada; Nobuko Harada; Yuki Ikeda; Kaemi Kimura; Naomi Kondo; Masashi Kanai; Ikko Kubo; Ryohei Yoshikawa; Yuichi Matsuda
Journal:  Heart Vessels       Date:  2021-06-21       Impact factor: 1.814

Review 6.  Exercise dyspnea in patients with COPD.

Authors:  Loredana Stendardi; Barbara Binazzi; Giorgio Scano
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

7.  Control and sensation of breathing during cycling exercise in hypoxia under naloxone: a randomised controlled crossover trial.

Authors:  Laurent Koglin; Bengt Kayser
Journal:  Extrem Physiol Med       Date:  2013-01-02

8.  The one repetition maximum test and the sit-to-stand test in the assessment of a specific pulmonary rehabilitation program on peripheral muscle strength in COPD patients.

Authors:  Andrea Zanini; Marina Aiello; Francesca Cherubino; Elisabetta Zampogna; Andrea Azzola; Alfredo Chetta; Antonio Spanevello
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-11-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.